Stocks Highjack By Analysts Estimates: Cypress Semiconductor (NASDAQ:CY), VeriSign (NASDAQ:VRSN)

Cypress Semiconductor Corporation (NASDAQ:CY) [Trend Analysis] swings ardently in active trading session, it shows upbeat performance surges of 2.03% to close at $12.04. Fundamentalist can give brighter side of a picture but an analyst can glow the darker parts stored in any investment. Let us view how analysts have ranked CY in recent few months. In ratings table the CY given BUY ratings by 7 analysts in current phase and 1 analyst suggest it as overweight security. None of analyst/s has SELL recommendation for current month on CY. While 7 number of analysts gave ratings for HOLD in current as compared to 1 analyst giving UNDERWEIGHT. As per remarks given by WSJ, overall consensus pool recommend it as Overweight security.

The stock was assessed in terms of profitability as current quarter EPS estimate trends showed $0.14 at current month while compared with $0.14 in a month ago. The stock next year first quarter current estimate trend for EPS was for $0.10 and on annual basis FY 2016 estimate trends at current was for $0.48 as compared to one month ago of $0.48, and for next year per share earnings estimates have $0.69.

The stock price of firm is moving up from its 20 days moving average with 3.78% and remote isolated positively from 50 days moving average with 6.20%. (Full [FREE Analysis] of NASDAQ:CY And Be Sure To Notice The Intermediate Period)

Moving toward the volatility measures, the price volatility of stock was 2.97% for a week and 2.66% for a month as well as price volatility’s Average True Range for 14 days was 0.32. The beta, which indicates risk in relegation to the market, remained 1.84. The firm past twelve months price to sales ratio was 2.11 and price to cash ratio remained 44.30. As far as the returns are concern, the return on equity was recorded as -30.20% and return on investment was -10.40% while its return on asset stayed at -18.20%.

VeriSign, Inc. (NASDAQ:VRSN) [Trend Analysis] considering as most desiring stocks in active trading lead, shares eased up after opening to traded at $80.23 with volume of 1.12 Million shares. The VRSN held a rough session during the week but was ready to get some critical analysis. The stock was assessed by a pool of analysts at WSJ and came out with some serious outcomes not to be avoided before making investment. The VRSN ratings chart showed that 5 gave HOLD ratings for the current month as 1 analyst opting for Overweight option for same period, whereas, 1 analyst out of pool gave UNDERWEIGHT rating. For stocks’ current month, 1 analyst opted for BUY ratings as compared to 2 opting for SELL in the same period. The stock price target chart showed average price target of 81.00 as compared to current price of 80.23.

Taking look on per share earnings estimates, its next year first quarter current estimate trend for EPS was for $0.91 and on annual basis FY 2016 estimate trends at current was for $3.56 as compared to one month ago of $3.55, and for next year per share earnings estimates have $3.82.

VRSN is ahead its 52-week low with 14.19%and going down from its 52-week high price with -12.78%. The company’s shares performance for the last one month was 5.47% and -1.33% in the previous week. As the revenues measures, firm has operation margin of 59.90% in the following twelve months with net profit margin of positive 38.70%. The Company showed a positive 38.70% in the net profit margin. Company’s annual sales growth for the past five year was 9.30%.

For latest Market Updates Subscribes Here

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *